High fat feeding is associated with increased blood pressure, sympathetic nerve activity and hypothalamic mu opioid receptors

Brain Research Bulletin

Volumn 61, Issue 5, 2003, Pages 511-519

  Barnes, Maria J ^a   Lapanowski, Karen ^b   Conley, Alexandria ^b   Rafols, Jose A ^a   Jen, K L Catherine ^a   Dunbar, Joseph C ^b  

^a WAYNE STATE UNIVERSITY   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Blood pressure; Fat diet; Obesity; Opioid receptors; Sympathetic nerve activity

Indexed keywords

BETA ENDORPHIN; GLUCOSE; INSULIN; LEPTIN; MU OPIATE RECEPTOR; OPIATE;

ANESTHESIA; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTONOMIC NERVOUS SYSTEM; BLOOD PRESSURE REGULATION; BLOOD SAMPLING; BODY FAT; CARDIOVASCULAR SYSTEM; CONTROLLED STUDY; FAT INTAKE; GLUCOSE BLOOD LEVEL; HYPOTHALAMUS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INSULIN BLOOD LEVEL; LIPID DIET; MALE; MEAN ARTERIAL PRESSURE; NERVE CONDUCTION; NONHUMAN; OBESITY; PRIORITY JOURNAL; RAT; REGULATORY MECHANISM; SYMPATHETIC NERVE; SYMPATHETIC TONE;

EID: 0141566812     PISSN: 03619230     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0361-9230(03)00188-6     Document Type: Article

References (33)

1. Agata J., Masuda A., Takada M., Higashiura K., Murakami H., Miyazaki Y., Shimamoto K. High plasma immunoreactive leptin level in essential hypertension. Am. J. Hypertens. 10:1997;1171-1174.
2. Barzilai N., Banerjee S., Hawkins M., Chen W., Rossetti L. Caloric restriction reverses hepatic insulin resistance in aging rats by decreasing visceral fat. J. Clin. Invest. 101:1998;1353-1361.
3. Barzilai N., Rossetti L. Relationship between changes in body composition and insulin responsiveness in models of the aging rat. Am. J. Physiol. 269:1995;E591-E597.
4. Brown J.L., Spicer M.T., Spicer L.J., Effect of high-fat diet on body composition and hormone responses to glucose tolerance test Endocrine. 19:2002;327-332.
5. Considine R.V., Sinha M.K., Heiman M.L., Kriauciunas A., Stephens T.W., Nyce M.R., Ohannesian J.P., Marco C.C., McKee L.J., Bauer T., Caro J.F. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N. Engl. J. Med. 334:1996;292-295.
6. Deutsch D., Jen K.L.-C., Grunberger G. Regulation of hepatic insulin receptor tyrosine kinase in rat models of sugar-induced insulin resistance. J. Lab. Clin. Med. 122:1993;421-425.
7. Dunbar J.C., Hu Y., Lu H. Intracerebroventricular leptin increases lumbar and renal sympathetic nerve activity and blood pressure in normal rats. Diabetes. 46:1997;2040-2043.
8. Dunbar J.C., Lu H. Leptin-induced increase in sympathetic nervous and cardiovascular tone is mediated by proopiomelanocortin (POMC) products. Brain Res. Bull. 50:1999;215-221.
9. Dunbar J.C., Lu H. Proopiomelanocortin (POMC) products in the central regulation of sympathetic and cardiovascular dynamics: studies on melanocortin and opioid interactions. Peptides. 21:2000;211-217.
10. Eimerl J., Feuerstein G. The effect of mu, delta, kappa, and epsilon opioid receptor agonist on heart rate and blood pressure of the pithed rat. Neuropeptides. 8:1986;351-358.
11. Faden A.I., Feuerstein G. Hypothalamic regulation of the cardiovascular and respiratory systems: role of specific opiate receptors. Br. J. Pharmacol. 79:1982;997-1002.
12. Feuerstein G., Faden A.I. Cardiovascular effects of dynorphin A-(1-8), dynorphin A-(1-13) and dynorphin A-(1-17) microinjected into the preptic medialis nucleus of the rat. Neuropeptides. 5:1984;295-298.
13. Feuerstein G., Siren A.L. The opioid peptides. A role in hypertension. Hypertension. 9:1987;561-565.
14. Feuerstein G., Siren A.L. Hypothalamic mu-opioid receptors in cardiovascular control: a review. Peptides. 9:1998;75-78.
15. Feuerstein G., Zerbe R.L., Faden A.I. Opiate receptors and cardiovascular control in conscious SHR and WKY rats. Hypertension. 5:1983;663-671.
16. Gulati A., Bhargava H.N. Characteristics of central binding sites for [3H] DAMGO in spontaneously hypertensive rats. Life Sci. 47:1990;159-166.
17. Hassen A.H., Feuerstein G.K., Faden A.I. Kappa opioid receptors modulate cardiorespiratory function in hindbrain nuclei of rat. J. Neurosci. 4:1984;2213-2221.
18. Hu F.B., Van Dan R.M., Lu S. Diet and risk of type II diabetes: the role of types of fat and carbohydrates. Diabetologia. 44:2001;805-817.
19. Kannel W.B. Fifty years of Framingham study contributions to understanding hypertension. J. Human Hypertens. 14:2000;83-90.
20. Kujirai K., Fahn S., Cadet J.L. Receptor autoradiography of mu and delta opioid peptide receptors in spontaneous hypertensive rats. Peptides. 12:1991;779-785.
21. Landsberg L., Krieger D.R. Obesity, metabolism, and the sympathetic nervous system. Am. J. Hypertens. 2:1989;125S-132S.
22. Levin E.R., Mills S., Weber M.A. Endogenous opioids and opiate antagonist modulate the blood pressure of the spontaneously hypertensive rat. Peptides. 7:1986;977-981.
23. Lovejoy J.C. The influence of dietary fat on insulin resistance. Curr. Diabetes Rep. 2:2002;435-440.
24. Lu H., Buison A., Jen K.L.-C., Dunbar J.C. Leptin resistance in obesity is characterized by decreased sensitivity to proopiomelanocortin products. Peptides. 21:2000;1485-1497.
25. Lu H., Duanmu Z., Houck C., Jen K.L.-C., Buison A., Dunbar J.C. Obesity due to high fat diet decreases the sympathetic nervous and cardiovascular responses to intracerebroventricular leptin in rats. Brain Res. Bull. 47:1998;331-335.
26. Pfeiffer A., Feuerstein G.K., Zerbe R.L., Faden A.I., Kopin I.J. Mu receptors mediate opioid cardiovascular effects at anterior hypothalamic pathways. Endocrinology. 113:1983;929-938.
27. Richard R.J., Thaker V., Reisin E. Obesity-related hypertension: its physiological basis and pharmacological approaches to its treatment. J. Human Hypertens. 12:1996;S59-S64.
28. Shek E., Brands M.W., Hall J.E. Chronic leptin infusion increases arterial blood pressure. Hypertension. 31:1998;409-414.
29. Szilagyi J.E. Endogenous opiates and the pathogenesis of hypertension. Clin. Exp. Hypertens. 1:1989;1-24.
30. Taylor J.W., Kaiser E.T. Opioid receptor selectivity of peptide models of β-endorphin. Int. J. Peptide Protein Res. 34:1989;75-80.
31. Van Loon G.R., Apel N.M., Ho D. Beta-endorphin-induced increases in plasma epinephrine, norepinephrine and dopamine in rats: inhibition of adrenal medullary response by intracerebral somatostatin. Brain Res. 212:1981;207-214.
32. Wang J., Obici S., Morgan K., Barzilai N., Feng Z., Rossetti L. Overfeeding rapidly induces leptin and insulin resistance. Diabetes. 50:2001;2786-2791.
33. Zhang R., Thaker V., Morse S., Reisen E. Renal and cardiovascular considerations of the nonpharmacological and pharmacological therapies of obesity-hypertension. J. Human Hypertens. 16:2002;819-827.